Price $92.44 |
Market Cap
13.36B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
82.3
|
P/B
12.62
|
P/S
17.3
|
Dividend %
-
|
|
P/CF
140.5
|
P/FCF
54.6
|
Op. Cash Flow
271.1K
|
FCF
1.6
|
|
Op. Margin
22.60%
|
Net Margin
21.20%
|
ROE
17.40%
|
ROI
14.80%
|
|
ROA
13.10%
|
EPS Growth
32.30%
|
Current Ratio
3.3
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Navidea Biopharmaceuticals Inc (NAVB) | $0.20 | - | - | 40.1M | Strong Buy |
| Integer Holdings Corp (ITGR) | $85.72 | - | - | 2.7B | Strong Buy |
| InfuSystem Holdings Inc (INFU) | $3.35 | - | - | 61.1M | Strong Buy |
| Correvio Pharma Corp (CORV) | $3.14 | - | - | 122.4M | Strong Buy |
| RTI Surgical Inc (RTIX) | $4.38 | - | - | 289.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
